Available Until 12/16/2024

Abstracting & Coding: Therapeutic Advances in HER2-Positive Breast Cancer

Dr. Ayed will discuss the biology and staging of HER2-positive breast cancer and the process for initiating the diagnostic workup and treatment options. He will provide an overview of the landscape of the evolving treatment of HER2-positive breast cancer, including biomarkers and new compounds and combinations that are showing promising results. 

Learning Objectives:

  • Review HER2-positive breast cancer epidemiology, biology, and staging.
  • Discuss current landscape of HER2-positive breast cancer diagnostic workup and treatment.
  • Highlight recent advances in HER2-directed treatments including biologics and targeted therapy.

Credit Information

Activity Number Credit Amount Accreditation Period
2022-013 1 CE April 18, 2022 - March 16, 2025